Nivolumab With or Without Ipilimumab in Treating Patients With Resectable Liver Cancer
Clinical trial NCT03222076 · COMPLETED
Trial details
- NCT number
- NCT03222076
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-28
- Primary completion
- 2022-09-14
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.